Markus Jerling
Direttore Tecnico/Scientifico/R&S presso ONCOZENGE AB
Posizioni attive di Markus Jerling
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ONCOZENGE AB | Direttore Tecnico/Scientifico/R&S | 01/05/2021 | - |
| KANCERA AB | Direttore Tecnico/Scientifico/R&S | 01/09/2023 | - |
| DIAMYD MEDICAL AB | Direttore Tecnico/Scientifico/R&S | - | - |
| Corporate Officer/Principal | - | - |
Storia della carriera di Markus Jerling
Precedenti posizioni note di Markus Jerling
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | 01/01/2004 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
| Astra Arcus AB | Corporate Officer/Principal | 01/01/1995 | 01/01/1998 |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Direttore Tecnico/Scientifico/R&S | 01/04/2007 | - |
Formazione di Markus Jerling
| Karolinska Institutet | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 7 |
| Stati Uniti | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ONCOZENGE AB | Health Technology |
| KANCERA AB | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Aziende private | 4 |
|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| Astra Arcus AB |
- Borsa valori
- Insiders
- Markus Jerling
- Esperienza
